Kathy Taylor

Head of Device Drug Qualification & Compatibility at Takeda Pharmaceuticals (formerly Nycomed) - Lexington, MA, US

Kathy Taylor's Colleagues at Takeda Pharmaceuticals (formerly Nycomed)
Uthra Sundaram

Executive Vice President, Head - Global Product & Launch Strategy (GPLS)

Contact Uthra Sundaram

Michelle Wilson

Associate Director, PDT IT Business Partner

Contact Michelle Wilson

Kern Briggs

Head of Global Patient Advocacy

Contact Kern Briggs

Sally Bs

Senior Regional Business Director GI/ Rare Disease

Contact Sally Bs

Eibhlin Carr

Quality Assurance Executive

Contact Eibhlin Carr

Alan Kehoe

API Plant Technologist

Contact Alan Kehoe

View All Kathy Taylor's Colleagues
Kathy Taylor's Contact Details
HQ
224-554-6500
Location
United States
Company
Takeda Pharmaceuticals (formerly Nycomed)
Kathy Taylor's Company Details
Takeda Pharmaceuticals (formerly Nycomed) logo, Takeda Pharmaceuticals (formerly Nycomed) contact details

Takeda Pharmaceuticals (formerly Nycomed)

Lexington, MA, US • >10000 Employees
Major Drugs

On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Branded Pharmaceuticals Gastroenterology Respiratory Conditions Inflammatory Diseases Pain Management Osteoporosis Treatment Over The Counter
Details about Takeda Pharmaceuticals (formerly Nycomed)
Frequently Asked Questions about Kathy Taylor
Kathy Taylor currently works for Takeda Pharmaceuticals (formerly Nycomed).
Kathy Taylor's role at Takeda Pharmaceuticals (formerly Nycomed) is Head of Device Drug Qualification & Compatibility.
Kathy Taylor's email address is ***@takeda.com. To view Kathy Taylor's full email address, please signup to ConnectPlex.
Kathy Taylor works in the Major Drugs industry.
Kathy Taylor's colleagues at Takeda Pharmaceuticals (formerly Nycomed) are Uthra Sundaram, Michelle Wilson, Jessica Crosbie, Kern Briggs, Sally Bs, Eibhlin Carr, Alan Kehoe and others.
Kathy Taylor's phone number is 224-554-6500
See more information about Kathy Taylor